Cynosure Lutronic Showcases Research at ASLMS 2026 with Strong Focus on XERF Technology

Cynosure Lutronic announced on the 10th that it participated in the 45th Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS 2026), showcasing its core portfolio and engaging in scholarly exchange with global medical professionals. This event serves as a pivotal platform for dermatologists, plastic surgeons, and medical device industry stakeholders to share the latest clinical research and technological advancements.

Held in Savannah, Georgia, ASLMS 2026 accepted a total of 29 abstracts featuring Cynosure Lutronic equipment, signifying a robust interest in the company's innovations. Notably, ten of these submissions focused on the rapidly growing dual monopolar radio frequency (RF) medical device, XERF, indicating its increasing relevance in the competitive global market.

The topics related to XERF research encompassed a wide range of both basic and clinical science, including the analysis of tissue responses based on dual-frequency monopolar RF at 6.78MHz and 2MHz, energy delivery characteristics based on depth selection, and evaluations of direct and peripheral effects using a 3D human skin model. Such comprehensive studies not only validate the efficacy of XERF but also position it strategically amid escalating market demands for advanced RF technologies.

The device was prominently featured during the Plenary Session—a segment dedicated to introducing cutting-edge medical technologies—drawing the attention of international practitioners. Dr. Jordan Wang and Dr. Jeffrey Esslinger led discussions on the latest trends in energy-based procedures, particularly those centered around RF applications, thereby enhancing the perceived clinical authority of Cynosure Lutronic's offerings.

Additionally, the company unveiled significant clinical study results pertaining to its flagship products: the 755nm wavelength Alexandrite laser PicoSure Pro, the non-invasive fractional laser Mosaic 3D, and the Nd:YAG laser DermaV. These findings reflect a diversified approach to treatment methodologies, substantiating the company’s strategy of delivering a comprehensive suite of cutting-edge devices to meet evolving consumer needs.

To facilitate hands-on learning, Cynosure Lutronic established a dedicated area known as the Cynosure Lutronic Learning Lab at the conference. Here, participating medical professionals were able to interact with key devices such as XERF, DermaV, and eCO2 3D, gaining firsthand insight into their operational principles and clinical applications. This initiative not only reinforced brand engagement but also deepened the participants' understanding of treatment protocols, potentially enhancing long-term customer loyalty and retention.

Ultimately, Cynosure Lutronic's robust presence at ASLMS 2026 underscores its commitment to advancing medical aesthetics through ongoing innovation and education. This signals a broader trend within the beauty industry, where expertise and technological integration become crucial differentiators in a competitive landscape.